Evidence map›Paper›PMID 32270431›Full record

ArticleIrish journal of medical science2020

Research on promoting liver fibrosis injury by the targeted regulation of miR-202 for HGF to activate HSC.

Xianli Niu, Shirong Nong, Junyuan Gong, Xin Zhang, Hui Tang, Tianhong Zhou, Wei Li

Abstract read
PubMed Publisher
In one paragraph

Article in Irish journal of medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xianli NiuKey Laboratory of Viral Biology Guangzhou, Department of Biology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China.
Shirong NongKey Laboratory of Viral Biology Guangzhou, Department of Biology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China.
Junyuan GongKey Laboratory of Viral Biology Guangzhou, Department of Biology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China.
Xin ZhangKey Laboratory of Viral Biology Guangzhou, Department of Biology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China.
Hui TangKey Laboratory of Viral Biology Guangzhou, Department of Biology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China.
Tianhong ZhouKey Laboratory of Viral Biology Guangzhou, Department of Biology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China.
Wei LiKey Laboratory of Viral Biology Guangzhou, Department of Biology, Jinan University, No.601, West Huangpu Avenue, Guangzhou, 510632, Guangdong, China. liwei201912@163.com.
Jinan University · CNZunyi Medical University · CN

Funding

AIDS and viral hepatitis and other major infectious disease prevention and control, National Science and technology major projects, sub topics New target research on anti HBV treatment 2012ZX10002006-003
6 · The paper itself

Abstract

backgroundLiver fibrosis is the primary cause of liver cirrhosis and hepatocellular carcinoma and leads to considerable morbidity and mortality. Recent studies have shown that microRNAs are associated with fibrotic processes in liver disorders, but the exact role of miR-202 is still unclear, and its related mechanisms are not fully understood.

aimsThe aim of this research is to analyze the regarded regulation of miR-202 on HGF and its role in the pathological progress of liver fibrosis.

methodsIn the present study, qRT-PCR was used to detect the expression level of miR-202 in serum of patients with liver fibrosis and to compare its expression in patients with different pathological stages. HGF was predicted to be the target gene of miR-202 by TargetScan and was verified by Dual-luciferase reporter gene assay. qRT-PCR and western blot were used to detect the regulatory effect of mir-202 on the mRNA and protein of HGF; effect of miR-202 on the expression of fibrosis factors α-smooth muscle actin (α-SMA), FSP1, and collagen was detected; effect of miR-202 on liver fibrosis in mice was detected by establishing CCL4-induced mouse model.

resultsWe found that the expression level of miR-202 in serum of patients with liver fibrosis was significantly higher than that of healthy people, and increased with the increase of fibrosis; miR-202 inhibited the expression level of mRNA and protein of HGF by combining with the 3'-UTR of HGF; the expression level of miR-202 significantly increased after hepatic stellate cells (HSC) were stimulated by AngII; the overexpression of miR-202 could up-regulate the expression of fibrotic factors α-SMA, FSP1, and collagen I. In addition, miR-202 up-regulated the expression of collagen I and collagen III in liver tissue of mice with liver fibrosis and promoted the progress of liver fibrosis.

conclusionsmiR-202 could negatively regulate the expression of target gene HGF, activated HSC, and increased the expression levels of various fibrosis factors, and the pathological process of liver fibrosis injury was promoted.

Indexed as

AnimalsFemaleHepatic Stellate CellsHepatocyte Growth FactorHumansLiver CirrhosisMaleMiceMicroRNAsMiddle AgedHepatocyte Growth FactorHGF protein, humanMicroRNAsMIRN202 microRNA, humanHGFHSC, liver fibrosismiR-202

Identifiers

PMID32270431
OpenAlexW3015323613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.